In vitro effect of benzodiazepines on polymorphonuclear leukocyte oxidative activity.
The effect of three benzodiazepine compounds, diazepam, flunitrazepam, and clorazepate, on oxidative activity of human polymorphonuclear leukocyte (PMN) was investigated. The oxidative activity of zymosan-stimulated PMN in the presence of three concentrations (10, 20, and 40 micrograms/ml) of these compounds was measured polarographically. In addition, zymosan-stimulated nitroblue tetrazolium (NBT) reduction was measured in the presence of various concentrations of flunitrazepam. All three compounds inhibited oxygen consumption of the PMN. The extent of inhibition was linear with respect to log-concentrations; oxygen consumption was reduced 50% for concentrations of diazepam, flunitrazepam, and clorazepate of 13 micrograms/ml, 56 micrograms/ml, and 285 micrograms/ml, respectively. In addition 30% and 100% inhibition of NBT reduction by flunitrazepam were observed at respective concentrations of 10 micrograms/ml and 60 micrograms/ml. The clinical relevance of these findings remains to be determined.
D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D003009:Clorazepate Dipotassium / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D005445:Flunitrazepam / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D009580:Nitroblue Tetrazolium; D010101:Oxygen Consumption / Q000187:drug effects*; D013268:Stimulation, Chemical; D015054:Zymosan / Q000494:pharmacology
D014151:Anti-Anxiety Agents; D009580:Nitroblue Tetrazolium; D005445:Flunitrazepam; D003009:Clorazepate Dipotassium; D015054:Zymosan; D003975:Diazepam